查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2024832

法布瑞氏症市場報告：按類型、診斷和治療、最終用戶和地區分類（2026-2034 年）

Fabry Disease Market Report by Type (Type 1, Type 2, and Others), Diagnosis and Treatment (Diagnosis, Treatment), End User (Hospitals, Homecare, Specialty Clinics, and Others), and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 147 Pages | 商品交期: 2-3個工作天內

價格

2025年，全球法布瑞氏症市場規模達23億美元。展望未來，IMARC Group預測，到2034年，該市場規模將達到38億美元，2026年至2034年的複合年成長率為5.78%。法布瑞氏症患者數量的增加以及對基因療法和酵素替代療法等有效新治療方法的需求不斷成長，是推動市場成長的主要因素。

法布瑞氏症，又稱α-半乳糖苷酶A缺乏症，是嚴重的X連鎖溶小體貯積症，由一種代謝多種脂質貯積物質和脂肪成分（如油脂、脂肪酸和蠟）所必需的酵素缺乏所引起。若未確診和治療，可導致血管和組織阻塞、進行性性腎衰竭、神經病變，甚至中風。目前，法布瑞氏症可透過酵素替代療法（ERT）和輔助性治療進行治療。此外，還可透過基因檢測、血液檢查和親和性測試進一步診斷，以預防腎臟和心臟問題的發生。這些方法可降低原發性和繼發性併發症的風險，並糾正潛在的酵素缺乏症。因此，醫院和專科診所廣泛採用多種方法對法布瑞氏症進行早期診斷和有效治療。

法布瑞氏症市場趨勢：

法布瑞氏症患者數量的不斷增加，以及對基因療法、酵素替代療法、基材減少療法和Chaperone療法等精準有效治療方法日益成長的需求，是推動市場成長的主要因素。反過來，這也帶動了口服和膠囊類藥物需求的成長，進一步促進了市場發展。此外，政府為促進醫療保健領域投資、開發突破性疾病治療方法所採取的積極監管措施，也為市場成長提供了支持。遠端醫療解決方案和居家照護環境等重大技術進步，也推動了法布瑞氏症診斷和治療領域的發展，並促進了市場成長。大眾對此疾病認知度的提高也是市場發展的重要促進因素。醫生和公眾對早期診斷和各種預防措施的認知不斷提高，也促進了市場成長。老年人口的持續成長，以及易患各種慢性疾病的人群，也是推動市場成長的另一個因素。其他推動市場前景光明的因素包括醫療保健基礎設施的顯著改善、對遺傳疾病治療進展的日益重視，以及為擴大治療方法和藥物組合而持續進行的研發活動。

本報告解答的主要問題：

  • 迄今為止，全球法布瑞氏症市場的發展趨勢是什麼？您預計未來幾年該市場將如何發展？
  • 全球法布瑞氏症市場的促進因素、限制因素和機會是什麼？
  • 主要區域市場有哪些？
  • 哪個國家是法布瑞氏症患者最具吸引力的市場？
  • 按類型分類的市場組成是什麼？
  • 按診斷和治療方式分類的市場區隔如何？
  • 依最終用戶分類的市場區隔如何？
  • 全球法布瑞氏症市場的競爭格局如何？
  • 全球法布瑞氏症市場的主要參與者和公司有哪些？

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球法布瑞氏症市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依類型

  • 1型
  • 類型 2
  • 其他

第7章 市場區隔：依診斷及治療分類

  • 診斷
    • 主要部分
      • 驗血
      • 基因檢測
      • 腸外檢測
      • 其他
  • 治療
    • 主要部分
      • 酵素替代療法
      • 口服療法
      • 輔助性治療
      • 其他

第8章 市場區隔：依最終用戶分類

  • 醫院
  • 居家照護
  • 專科診所
  • 其他

第9章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第10章 促進因素、阻礙因素和機遇

第11章：價值鏈分析

第12章：波特五力分析

第13章：價格分析

第14章 競爭格局

  • 市場結構
  • 大公司
  • 主要公司簡介
    • Amicus Therapeutics
    • Freeline
    • Idorsia Pharmaceuticals Ltd
    • JCR Pharmaceuticals Co. Ltd
    • Protalix BioTherapeutics
    • Sangamo Therapeutics Inc.
Product Code: SR112026A6668

The global fabry disease market size reached USD 2.3 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 3.8 Billion by 2034, exhibiting a growth rate (CAGR) of 5.78% during 2026-2034. The increasing number of patients suffering from fabry disease and the escalating need for effective novel therapies, such as genetic and enzyme replacement therapy, represent some of the key factors driving the market.

Fabry disease, or alpha galactosidase-A deficiency, represents a severe x-linked lysosomal inherited disorder that is caused by the lack of enzymes that are required to metabolize various lipid storage and fat-like components, including oils, fatty acids, and waxes. If left undiagnosed or untreated, it might result in clogging of blood vessels and tissue, progressive kidney failures, nerve damage, and even strokes. Currently, fabry disease can be treated with the support of enzyme replacement therapies (ERT) and adjunct therapy. Apart from this, it can be further diagnosed through genetic, blood, and parenteral examinations to inhibit the occurrence of kidney and heart problems. These approaches prevent the risk of developing first and second-level complications and correct underlying enzyme deficiency. Consequently, hospitals and specialty clinics widely utilize various procedures for the timely diagnosis and effective treatment of the Fabry disease.

Fabry Disease Market Trends:

The increasing number of patients suffering from fabry disease and the escalating need for precise and effective therapies, such as genetic, enzyme replacement substrate reduction, and chaperone treatments to stabilize individuals from suffering disease, are primarily driving the market growth. In line with this, the rising demand for orally administered medications and capsule for disease treatment is acting as another growth-inducing factor. Additionally, the favorable initiatives being undertaken by regulatory bodies to invest in the healthcare sector for the designing of breakthrough disease treatment options are supporting the market growth. Moreover, significant technological advancements, such as the introduction of telemedicine solutions and home care settings for the diagnosis and treatment of Fabry disease, are favoring the market growth. The market is also significantly driven by the rising awareness regarding the disease. There is an increasing consciousness regarding the availability of early-stage diagnosis and multiple preventive measures amongst physicians and individuals, which is contributing to the market growth. The steadily increasing geriatric population, which is susceptible to any kind of chronic ailments, is another factor contributing to the market growth. Other factors, such as significant improvements in the healthcare infrastructure, an enhanced focus on the advancement of the genetic disease therapies, and continuous research and development (R&D) activities to expand treatment and medication portfolios, are creating a positive outlook for the market.

Key Market Segmentation:

This report provides an analysis of the key trends in each segment of the global fabry disease market, along with forecasts at the global, regional, and country level from 2026-2034. The report has categorized the market based on type, diagnosis and treatment, and end user.

Type Insights:

  • Type 1
  • Type 2
  • Others

The report has also provided a detailed breakup and analysis of the fabry disease market based on the type. This includes Type 1, Type 2 and others.

Diagnosis and Treatment Insights:

  • Diagnosis
  • Blood Test
  • Genetic Test
  • Parenteral Test
  • Others
  • Treatment
  • Enzyme Replacement Therapy
  • Oral Therapy
  • Adjunct Therapy
  • Others

End User Insights:

  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others

Regional Insights:

  • North America
  • United States
  • Canada
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and Middle East and Africa. According to the report, North America was the largest market for Fabry disease. Some of the factors driving the North America fabry disease market included the increasing prevalence of fabry disease and the ongoing approvals of advanced therapeutics by regional governments for the disorder treatment.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global fabry disease market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Amicus Therapeutics, Freeline, Idorsia Pharmaceuticals Ltd, JCR Pharmaceuticals Co. Ltd, Protalix BioTherapeutics, Sangamo Therapeutics Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

  • How has the global fabry disease market performed so far and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global fabry disease market?
  • What are the key regional markets?
  • Which countries represent the most attractive fabry disease markets?
  • What is the breakup of the market based on the type?
  • What is the breakup of the market based on the diagnosis and treatment?
  • What is the breakup of the market based on the end user?
  • What is the competitive structure of the global fabry disease market?
  • Who are the key players/companies in the global fabry disease market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Fabry Disease Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Type 1
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Type 2
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Others
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Diagnosis & Treatment

  • 7.1 Diagnosis
    • 7.1.1 Market Trends
    • 7.1.2 Key Segments
      • 7.1.2.1 Blood Test
      • 7.1.2.2 Genetic Test
      • 7.1.2.3 Parenteral Test
      • 7.1.2.4 Others
    • 7.1.3 Market Forecast
  • 7.2 Treatment
    • 7.2.1 Market Trends
    • 7.2.2 Key Segments
      • 7.2.2.1 Enzyme Replacement Therapy
      • 7.2.2.2 Oral Therapy
      • 7.2.2.3 Adjunct Therapy
      • 7.2.2.4 Others
    • 7.2.3 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Homecare
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Specialty Clinics
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 Drivers, Restraints, and Opportunities

  • 10.1 Overview
  • 10.2 Drivers
  • 10.3 Restraints
  • 10.4 Opportunities

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Amicus Therapeutics
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Freeline
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Idorsia Pharmaceuticals Ltd
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
    • 14.3.4 JCR Pharmaceuticals Co. Ltd
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Protalix BioTherapeutics
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Sangamo Therapeutics Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Fabry Disease Market: Major Drivers and Challenges
  • Figure 2: Global: Fabry Disease Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Fabry Disease Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 4: Global: Fabry Disease Market: Breakup by Type (in %), 2025
  • Figure 5: Global: Fabry Disease Market: Breakup by Diagnosis & Treatment (in %), 2025
  • Figure 6: Global: Fabry Disease Market: Breakup by End User (in %), 2025
  • Figure 7: Global: Fabry Disease Market: Breakup by Region (in %), 2025
  • Figure 8: Global: Fabry Disease (Type 1) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 9: Global: Fabry Disease (Type 1) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 10: Global: Fabry Disease (Type 2) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 11: Global: Fabry Disease (Type 2) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 12: Global: Fabry Disease (Other Types) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 13: Global: Fabry Disease (Other Types) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 14: Global: Fabry Disease (Diagnosis) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 15: Global: Fabry Disease (Diagnosis) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 16: Global: Fabry Disease (Treatment) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 17: Global: Fabry Disease (Treatment) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 18: Global: Fabry Disease (Hospitals) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 19: Global: Fabry Disease (Hospitals) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 20: Global: Fabry Disease (Homecare) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 21: Global: Fabry Disease (Homecare) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 22: Global: Fabry Disease (Specialty Clinics) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 23: Global: Fabry Disease (Specialty Clinics) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 24: Global: Fabry Disease (Other End Users) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 25: Global: Fabry Disease (Other End Users) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 26: North America: Fabry Disease Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 27: North America: Fabry Disease Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 28: United States: Fabry Disease Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 29: United States: Fabry Disease Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 30: Canada: Fabry Disease Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 31: Canada: Fabry Disease Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 32: Asia-Pacific: Fabry Disease Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 33: Asia-Pacific: Fabry Disease Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 34: China: Fabry Disease Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 35: China: Fabry Disease Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 36: Japan: Fabry Disease Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 37: Japan: Fabry Disease Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 38: India: Fabry Disease Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 39: India: Fabry Disease Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 40: South Korea: Fabry Disease Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 41: South Korea: Fabry Disease Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 42: Australia: Fabry Disease Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 43: Australia: Fabry Disease Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 44: Indonesia: Fabry Disease Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 45: Indonesia: Fabry Disease Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 46: Others: Fabry Disease Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 47: Others: Fabry Disease Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 48: Europe: Fabry Disease Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 49: Europe: Fabry Disease Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 50: Germany: Fabry Disease Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 51: Germany: Fabry Disease Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 52: France: Fabry Disease Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 53: France: Fabry Disease Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 54: United Kingdom: Fabry Disease Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 55: United Kingdom: Fabry Disease Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 56: Italy: Fabry Disease Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 57: Italy: Fabry Disease Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 58: Spain: Fabry Disease Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 59: Spain: Fabry Disease Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 60: Russia: Fabry Disease Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 61: Russia: Fabry Disease Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 62: Others: Fabry Disease Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 63: Others: Fabry Disease Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 64: Latin America: Fabry Disease Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 65: Latin America: Fabry Disease Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 66: Brazil: Fabry Disease Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 67: Brazil: Fabry Disease Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 68: Mexico: Fabry Disease Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 69: Mexico: Fabry Disease Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 70: Others: Fabry Disease Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 71: Others: Fabry Disease Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 72: Middle East and Africa: Fabry Disease Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 73: Middle East and Africa: Fabry Disease Market: Breakup by Country (in %), 2025
  • Figure 74: Middle East and Africa: Fabry Disease Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 75: Global: Fabry Disease Industry: Drivers, Restraints, and Opportunities
  • Figure 76: Global: Fabry Disease Industry: Value Chain Analysis
  • Figure 77: Global: Fabry Disease Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Fabry Disease Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Fabry Disease Market Forecast: Breakup by Type (in Million USD), 2026-2034
  • Table 3: Global: Fabry Disease Market Forecast: Breakup by Diagnosis & Treatment (in Million USD), 2026-2034
  • Table 4: Global: Fabry Disease Market Forecast: Breakup by End User (in Million USD), 2026-2034
  • Table 5: Global: Fabry Disease Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 6: Global: Fabry Disease Market: Competitive Structure
  • Table 7: Global: Fabry Disease Market: Key Players